Key facts
- Silver Point Capital L.P. filed SCHEDULE 13D/A for Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ).
- Disclosed ownership: 15%.
- Date of event: 20 May 2026.
Silver Point Capital L.P. - 20 May 2026 SCHEDULE 13D/A Report for Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ)
- Filing Manager
- Silver Point Capital L.P.
- Reporting Manager
- Silver Point Capital, L.P.
- Symbol
- MNKTQ
- Shares outstanding
- 39,705,355 shares
- Disclosed Ownership
- 6,035,214 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13D/A
- Filing time
- 22 May 2026, 16:05:03 UTC
- Date of event
- 20 May 2026
- Previous filing
- 17 Apr 2026
- SEC
- View on sec.gov
Key filing fact
Silver Point Capital L.P. disclosed 15% ownership in Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ) on 20 May 2026.
Change
- Previous schedule filing date: 17 Apr 2026.
- Current filing was accepted on 22 May 2026, 16:05.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Silver Point Capital, L.P. | 15% | 6,035,214 | 0 | 6,035,214 | /s/ Steven Weiser | Steven Weiser/Authorized Signatory | 0001332784 |
| Edward A. Mule | 15% | 6,035,214 | 0 | 6,035,214 | /s/ Steven Weiser | Steven Weiser/Attorney-in-fact | 0001029625 |
| Robert J. O'Shea | 15% | 6,035,214 | 0 | 6,035,214 | /s/ Steven Weiser | Steven Weiser/Attorney-in-fact | 0001382617 |
CIK / CUSIP context first